BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34326358)

  • 1. The beneficial effects of menopausal hormone therapy on renal survival in postmenopausal Korean women from a nationwide health survey.
    Ahn SY; Choi YJ; Kim J; Ko GJ; Kwon YJ; Han K
    Sci Rep; 2021 Jul; 11(1):15418. PubMed ID: 34326358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between menopausal hormone therapy and the risk of gastric cancer: A Korean nationwide population-based cohort study.
    Han KH; Choi YJ; Han K; Shin CM; Park NH; Lee DH
    Maturitas; 2024 Jun; 184():107960. PubMed ID: 38460415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knee osteoarthritis and menopausal hormone therapy in postmenopausal women: a nationwide cross-sectional study.
    Jung JH; Bang CH; Song GG; Kim C; Kim JH; Choi SJ
    Menopause; 2018 Dec; 26(6):598-602. PubMed ID: 30586007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of menopausal hormone therapy on cardiovascular diseases and type 2 diabetes in middle-aged postmenopausal women: analysis of the Korea National Health Insurance Service Database.
    Kim JE; Choi J; Park J; Shin A; Choi NK; Choi JY
    Menopause; 2021 Sep; 28(11):1225-1232. PubMed ID: 34520413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women.
    Kim H; Kang MJ; Baek JK; Lee JK; Choi EA; Yun BH; Kim EH; Seo SK
    Climacteric; 2024 Apr; 27(2):165-170. PubMed ID: 37947171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of menopausal hormone therapy use in Korea (2002-2013): A nationwide cohort study.
    Park CY; Lim JY; Kim WH; Kim SY; Park HY
    Maturitas; 2021 Apr; 146():57-62. PubMed ID: 33722365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopausal hormone therapy may increase non-allergic rhinitis among postmenopausal women: Results from the Korea National Health and Nutrition Examination Survey (2010-2012).
    Choi JH; Hwang SH; Suh JD; Kim JK; Hong SC; Lim YC; Kim SN; Cho JH
    Maturitas; 2017 Aug; 102():46-49. PubMed ID: 28610682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopausal Hormone Therapy Is Associated With Increased Risk of Fecal Incontinence in Women After Menopause.
    Staller K; Townsend MK; Khalili H; Mehta R; Grodstein F; Whitehead WE; Matthews CA; Kuo B; Chan AT
    Gastroenterology; 2017 Jun; 152(8):1915-1921.e1. PubMed ID: 28209529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopausal hormone therapy and risk of seropositive rheumatoid arthritis: A nationwide cohort study in Korea.
    Yuk JS; Seo YS; Im YH; Kim JH
    Semin Arthritis Rheum; 2023 Dec; 63():152280. PubMed ID: 37857046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study.
    Velentzis LS; Banks E; Sitas F; Salagame U; Tan EH; Canfell K
    PLoS One; 2016; 11(3):e0146494. PubMed ID: 27008039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.
    Gleason CE; Dowling NM; Wharton W; Manson JE; Miller VM; Atwood CS; Brinton EA; Cedars MI; Lobo RA; Merriam GR; Neal-Perry G; Santoro NF; Taylor HS; Black DM; Budoff MJ; Hodis HN; Naftolin F; Harman SM; Asthana S
    PLoS Med; 2015 Jun; 12(6):e1001833; discussion e1001833. PubMed ID: 26035291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopausal hormone therapy and gallbladder disease: the Study of Health in Pomerania (SHIP).
    Schwarz S; Völzke H; Baumeister SE; Hampe J; Dören M
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):51-9. PubMed ID: 17437513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is breast cancer risk the same for all progestogens?
    Stute P
    Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of ghrelin and leptin receptor levels in postmenopausal women who received oral or transdermal menopausal hormonal therapy.
    Ruszkowska B; Sokup A; Kulwas A; Socha MW; Góralczyk K; Góralczyk B; Rość D
    J Zhejiang Univ Sci B; 2012 Jan; 13(1):35-42. PubMed ID: 22205618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.
    Simin J; Liu Q; Wang X; Fall K; Williams C; Callens S; Engstrand L; Brusselaers N
    Acta Oncol; 2021 Jul; 60(7):881-887. PubMed ID: 33861686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of menopausal hormone therapy on the risk of ovarian cancer: Health Insurance Database in South Korea-based cohort study.
    Yuk JS; Kim M
    Menopause; 2023 May; 30(5):490-496. PubMed ID: 37022299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular effects of estrogenic menopausal hormone therapy.
    Reslan OM; Khalil RA
    Rev Recent Clin Trials; 2012 Feb; 7(1):47-70. PubMed ID: 21864249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.
    Masood DE; Roach EC; Beauregard KG; Khalil RA
    Curr Drug Metab; 2010 Oct; 11(8):693-714. PubMed ID: 21189141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MHT: How and how long in healthy women above 65?].
    Wiegratz I
    Ther Umsch; 2021; 78(8):457-464. PubMed ID: 34555970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of osteoporotic fractures after discontinuation of menopausal hormone therapy: results from the E3N cohort.
    Engel P; Fabre A; Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
    Am J Epidemiol; 2011 Jul; 174(1):12-21. PubMed ID: 21555715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.